Home
Images
Vectors
Videos
Stock image Prague,Czech Republic-August 7 2024: FORXIGA box of medication with DAPAGLIFLOZIN active substance by ASTRAZENECA,used for treatment of Type 2 diabetes,heart failure.
Published:
Aug.16, 2024 08:36:50
Author:
jaroslav.semerad@gmail.com
Views:
0
Downloads:
0
File type:
image
/
jpg
File size:
1.8 MB
Orginal size:
4032
x
3024
px
Available sizes:
S
(500 x 375)
M
(1000 x 750)
L
(2000 x 1500)
XL
(4032 x 3024)
EL0
(4032 x 3024)
Level:
beginner
Download Image
Image topics:
Box
Health
Medicine
Healthcare
Pharmacy
Prescription
Treatment
Disease
Science
Substance
Medicament
Medication
Pharmaceutical
Drugs
Tablets
Drugstore
Diabetes
Heart Failure
Active Substance
Heart Health
Diabetes Management
Diabetes Control
Astrazeneca
Cardiovascular Care
Forxiga
Glucose Control
Dapagliflozin
Glucose Regulation
SGLT2 Inhibitor
Type 2 Diabetes Treatment
Type 2 Diabetes Care
Heart Failure Treatment
Diabetes And Heart Failure
SGLT2 Inhibitor Therapy
FORXIGA Dapagliflozin
AstraZeneca Medication
Dapagliflozin Tablets
FORXIGA 2024
AstraZeneca FORXIGA
Similar stock images
Prague,Czech Republic-June6 2023: FORXIGA (dapagliflozin), Diabetes Medication From Gliflozin Group, Sglt2 Inhibitor.
4032 × 3024
Prague, Czech Republic - July 10 2024: FORXIGA Box Of Medication With DAPAGLIFLOZIN Active Substance By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Heart Failure.
4032 × 3024
Prague, Czech Republic - July 10 2024: FORXIGA Box Of Medication With DAPAGLIFLOZIN Active Substance By ASTRAZENECA, Used For Treatment Of Type 2 Diabetes And Heart Failure.
4032 × 3024
Prague, Czech Republic - July 13, 2024: ROLPRYNA Tablets With ROPINIROLE Active Substance By KRKA, Used For Parkinson's Disease And Restless Legs Syndrome Treatment.
4032 × 3024
Prague, Czech Republic - July 13, 2024: ROLPRYNA Tablets With ROPINIROLE Active Substance By KRKA, Used For Parkinson's Disease And Restless Legs Syndrome Treatment.
4032 × 3024
Prague,Czech Republic-August 7 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK,used For Treatment Of Obesity
4032 × 3024
Prague, Czech Republic - July 10 2024: SAXENDA Box Of Medication With LIRAGLUTIDE Active Substance By NOVO NORDISK, Used For Weight Loss And Diabetes Management.
4032 × 3024
Prague, Czech Republic - JULY 10 2024: Dursea Box Of Medication With Desmopressin Active Substance By Egis Pharmaceuticals, Used For Treatment Of Diabetes Insipidus And Nocturnal Enuresis.
4032 × 3024